NOILE IMMUNE BIOTECH INC has a total of 32 patent applications. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are LI HUASHUN, ASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD and NANJING IASO BIOTHERAPEUTICS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | Singapore | 3 | |
#5 | Taiwan | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | Republic of Korea | 2 | |
#10 | United States | 2 | |
#11 | Chile | 1 | |
#12 | Israel | 1 | |
#13 | Japan | 1 | |
#14 | Mexico | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Sakoda Yukimi | 22 |
#2 | Tamada Koji | 22 |
#3 | Ishizaki Hidenobu | 11 |
#4 | Adachi Keishi | 11 |
#5 | Tatamiya Takayuki | 4 |
#6 | Yamaguchi Akiko | 4 |
#7 | Yukimi Sakoda | 4 |
#8 | Koji Tamada | 4 |
#9 | Hidenobu Ishizaki | 3 |
#10 | Take Chihiro | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021079705A1 | Genetically modified cell production system | |
CA3111170A1 | Car-expressing t cells and car expression vector | |
WO2020017479A1 | Anti-gpc3 single-chain antibody-containing car | |
EP3730612A1 | Immunocompetent cell that expresses a cell surface molecule specifically recognizing human mesothelin, il-7 and ccl19 | |
CA3057811A1 | Chimeric antigen receptor |